Focused insights: Data implications of ADCs in NSCLC treatment
touchFOCUS for touchRESPIRATORY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert
Prof. Céline Mascaux, Strasbourg University, Strasbourg, France
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca.
This…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.